Share on StockTwits

Thermo Fisher Scientific (NYSE:TMO) VP Seth H. Hoogasian sold 10,577 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $120.77, for a total transaction of $1,277,384.29. Following the sale, the vice president now directly owns 42,348 shares of the company’s stock, valued at approximately $5,114,368. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

TMO has been the subject of a number of recent research reports. Analysts at Stifel Nicolaus initiated coverage on shares of Thermo Fisher Scientific in a research note on Monday, August 11th. They set a “buy” rating and a $150.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Thermo Fisher Scientific in a research note on Thursday, August 7th. They now have a $126.00 price target on the stock. Finally, analysts at Macquarie reiterated an “outperform” rating on shares of Thermo Fisher Scientific in a research note on Thursday, July 24th. They now have a $135.00 price target on the stock, up previously from $130.00. Two research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $134.69.

Shares of Thermo Fisher Scientific (NYSE:TMO) traded down 0.01% on Thursday, hitting $120.07. The stock had a trading volume of 1,250,386 shares. Thermo Fisher Scientific has a 1-year low of $88.44 and a 1-year high of $127.63. The stock’s 50-day moving average is $121.1 and its 200-day moving average is $119.9. The company has a market cap of $47.950 billion and a P/E ratio of 31.21.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings data on Wednesday, July 23rd. The company reported $1.72 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.62 by $0.10. The company had revenue of $4.32 billion for the quarter, compared to the consensus estimate of $4.25 billion. During the same quarter in the prior year, the company posted $1.32 earnings per share. The company’s quarterly revenue was up 33.4% on a year-over-year basis. Analysts expect that Thermo Fisher Scientific will post $6.94 EPS for the current fiscal year.

Thermo Fisher Scientific Inc (NYSE:TMO) is engaged in serving science.

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.